Russia-Ukraine Update

RNS Number : 5439D
Templeton Emerging Markets IT PLC
03 March 2022
 

 

STOCK EXCHANGE ANNOUNCEMENT

Templeton Emerging Markets Investment Trust plc (the "Company")

 

Legal Entity Identifier 5493002NMTB70RZBXO96

 

Update on the Company's holdings in Russian companies following recent developments in Ukraine

Following Russia's invasion of Ukraine, our thoughts are first and foremost with the victims of the humanitarian crisis that is unfolding, as we monitor the resulting economic and market implications for the Company and its portfolio holdings.

The situation is fluid and changing rapidly from day to day, but it is clear that sanctions impacting Russia and Russian companies will be in place for some time and that further market volatility is to be expected.

As a result, we continue to review the Company's portfolio for direct and indirect exposure to Russia.

In this regard, we can report that the Company held securities in the following Russian companies as at 1 March 2022.

Holding

% of TEMIT NAV

Lukoil PJSC

0.33

Yandex NV

0.25

VK Co Ltd

0.02

Sberbank of Russia PJSC

0.02

Gazprom PJSC

0.03

Russia

0.65

Source: FT Risk; Note: Weights as of 1 March 2022. For securities with halted trading or closed stock exchanges, a fair value is determined by analysing various factors including security-specific and market level proxies, in accordance with established Fair Value policies and procedures.

 

All holdings in the above table are in foreign listed securities (either primary US listing or ADRs/GDRs).

 

ENDS

 

For further information please contact:

Winterflood Investment Trusts (Corporate Broker) Neil Langford on + 44 (0) 20 3100 0000

Saira Khan, Franklin Templeton Investments on +44 20 7073 8550 or saira.khan@franklintempleton.co.uk  

Company Secretarial Team temitcosec@franklintempleton.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJJMBTMTMMBPT
UK 100

Latest directors dealings